Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Northern Virginia Plastic Surgeon Dr. Amir Ghaznavi Uses alloClae® to Restore Volume After Major Weight Loss

AMG Plastic Surgery

News provided by

AMG Plastic Surgery

Oct 05, 2026, 09:02 ET

Share this article

Share toX

Share this article

Share toX

Off-the-shelf donor fat restores targeted volume, with no liposuction, for patients who have too little fat left to graft after major weight loss

HERNDON, Va., Oct. 5, 2026 /PRNewswire/ -- Patients who lose weight on GLP-1 medications often lose fat from the buttocks and hands faster than anywhere else. Many have too little fat left to harvest for grafting. Amir Mahan Ghaznavi, MD, MBA, FACS, a dual board-certified plastic surgeon and founder of AMG Plastic Surgery, uses alloClae® to restore that volume for patients in Northern Virginia. It is a donor-derived structural adipose tissue product.

Continue Reading
AMG Plastic Surgery
AMG Plastic Surgery

alloClae is a sterile, hydrated adipose allograft composed of non-viable intact adipocytes, extracellular matrix, lipids, and connective tissue. It is intended to provide cushioning and support in localized areas of the body where adipose tissue naturally exists.

Unlike traditional autologous fat grafting, which requires harvesting a patient's own fat through liposuction, alloClae provides structural adipose tissue that is ready for placement. At AMG Plastic Surgery, it is placed in the office under local anesthesia, with no liposuction donor site and no general anesthesia. Most patients return to desk work in one to two days.

"When a patient has lost a lot of weight, there is often not enough fat left to move," said Dr. Ghaznavi. "alloClae lets me restore a modest amount of volume in an office visit, awake, with no liposuction and no donor site. The key is selecting the appropriate patient and placing the volume where it is best suited to their anatomy and goals."

A Different Approach to Targeted Body Contouring

At AMG Plastic Surgery, Dr. Ghaznavi considers alloClae for patients seeking targeted volume restoration in areas such as the hips, buttocks, hands, scars, and certain breast contour irregularities.

For example, additional volume may be considered to soften the appearance of hip dips, refine selected buttock contours, restore volume to aging hands, or improve certain depressions associated with scars or previous body-contouring procedures. After major weight loss, he stages alloClae alongside post-weight-loss body contouring surgery when loose skin is also present.

The amount of alloClae required depends on the treatment area, the degree of correction sought, and the patient's individual anatomy. Dr. Ghaznavi emphasizes that alloClae is not a substitute for every fat-transfer or body-contouring procedure. Patients seeking substantial volume increases may be better candidates for traditional autologous fat grafting or another surgical approach.

Dr. Ghaznavi's Experience in Fat Grafting and Body Contouring

Dr. Ghaznavi's published research on body contouring after major weight loss appeared in the Plastic and Reconstructive Surgery journal and discusses the benefits of body contouring and maintaining weight loss. 

Dr. Ghaznavi has performed approximately 800 liposuction and fat-grafting procedures over his career, as well as many alloClae treatments.

"alloClae is a product. The result is the placement," said Dr. Ghaznavi. "Place it too deep, and you waste product. Place it too shallow and you risk visible lumps. Knowing where fat lives in each part of the body is what makes the difference."

What Patients Should Know About alloClae

alloClae is processed from screened donor fat tissue by Tiger Aesthetics, which distributes it as a human tissue product (HCT/P) under FDA tissue regulations. It is not an FDA-approved drug or device. Donor eligibility includes screening and testing intended to reduce the risk of transmitting relevant communicable diseases.

The processed tissue contains no living cells and has no systemic effect.

Dr. Ghaznavi tells patients to expect results to last 12 to 18 months, and some keep their results longer. alloClae has been available since 2024, so long-term data are still being collected, and he does not promise a duration beyond what he has seen.

As with any medical procedure, alloClae carries potential risks and is not appropriate for every patient. Potential complications identified in the product's safety information include cyst or nodule formation, pain, infection, hematoma, allergic or immune responses, anaphylaxis and skin discoloration at the treatment site. alloClae should not be used in patients with active infection, severe allergen sensitivities, or a history of anaphylaxis.

Individual results and duration can vary, and no specific aesthetic outcome can be guaranteed. A consultation with a board-certified plastic surgeon is necessary to determine whether alloClae or another body-contouring procedure is appropriate for an individual patient.

About Amir Mahan Ghaznavi, MD, MBA, FACS

Dr. Amir Mahan Ghaznavi is board-certified by both the American Board of Plastic Surgery and the American Board of Surgery. He completed his general surgery training at Maimonides Medical Center in Brooklyn, New York, followed by plastic surgery training at Henry Ford Hospital and advanced microsurgery fellowship training at Cleveland Clinic.

Dr. Ghaznavi later joined the Department of Plastic and Reconstructive Surgery at Cleveland Clinic, where he developed a multispecialty lymphedema program and led reconstructive surgical initiatives. He has authored research articles, abstracts, and book chapters. He has presented his work at medical conferences throughout the United States.

Dr. Ghaznavi currently serves as Vice-Chair of the American Society of Plastic Surgeons Cosmetic Subcommittee and was named a Northern Virginia Magazine Top Doctor in 2026.

AMG Plastic Surgery specializes in breast and body contouring, including body contouring after major weight loss, as well as non-surgical aesthetic procedures for patients from Reston, Fairfax, Herndon, and communities throughout Northern Virginia and the Washington, D.C. region. The practice is located at 13454 Sunrise Valley Dr., Suite 130, Herndon, VA 20171.

For more information about alloClae body contouring or to schedule a consultation with Dr. Ghaznavi, please visit amgplasticsurgery.com/alloclae-filler or call 703-239-3190.

Media Contact
Dr. Amir Ghaznavi
AMG Plastic Surgery
703-239-3190
[email protected]
AMGPlasticSurgery.com

SOURCE AMG Plastic Surgery

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Internal Bra Surgery Specialist Dr. Amir Ghaznavi Reports Growing Patient Interest in Northern Virginia

Internal Bra Surgery Specialist Dr. Amir Ghaznavi Reports Growing Patient Interest in Northern Virginia

AMG Plastic Surgery founder Dr. Amir Ghaznavi, a dual board-certified plastic and reconstructive surgeon, is seeing a notable rise in patients...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.